双肺移植后单肺再移植与双肺再移植的结局比较
该回顾性队列研究基于美国器官获取与移植网络数据库2005年5月至2022年12月的数据,纳入891例初次双肺移植后接受再移植的患者,其中双肺再移植698例(78.3%)、单肺再移植193例(21.7%)。双肺再移植组长期生存显著优于单肺再移植组,倾向评分加权多变量模型中双肺再移植组随访期间任何时点死亡风险降低28%(HR 0.72;95%CI 0.57-0.91;结论认为单肺再移植的微创优势短期获益有限且长期生存更差,双肺再移植应作为初次双肺移植后再移植的标准术式。
要点
- 初次双肺移植后再移植患者中,双肺再移植占78.3%,单肺再移植占21.7%。
核心结论
- 单肺再移植的微创优势短期获益有限,且与显著更差的长期生存相关。
- 双肺再移植应继续作为初次双肺移植后再移植的标准术式。
研究设计与样本
- 回顾性分析美国器官获取与移植网络/器官共享联合网络数据库2005年5月至2022年12月的数据。
- 排除多器官移植、多次再移植及初次移植状态未知的肺再移植。
- 共纳入891例患者,双肺再移植698例(78.3%),单肺再移植193例(21.7%)。
临床怎么用
- 初次双肺移植后需再移植时,应优先选择双肺再移植而非单肺再移植。
- 单肺再移植虽创伤较小,但不应以牺牲长期生存为代价而常规选用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare outcomes of single-lung retransplantation (SLRTx) and double-lung retransplantation (DLRTx) after an initial double-lung transplantation. METHODS: The Organ Procurement and Transplantation Network/United Network for Organ Sharing database between May 2005 and December 2022 was retrospectively analyzed. Multiorgan transplantations, repeated retransplantations, and lung retransplantations when the status of the initial transplantation was unknown were excluded. RESULTS: A total of 891 patients were included in the analysis, included 698 (78.3%) with DLRTx and 193 (21.7%) with SLRTx. The mean lung allocation score was higher in the DLRTx group (59.6 ± 20.7 vs 55.1 ± 19.3; P = .007). The use of extracorporeal membrane oxygenation (ECMO) bridge to lung transplantation was similar in the 2 groups (P = .125), as was waitlist time (P = .610). The need for mechanical ventilation (54.6% vs 35.8%; P = .005) and ECMO (17.9% vs 9.0%; P = .069) at 72 hours post-transplantation was greater in the DLRTx group. However, median post-transplantation hospital stay (21.5 [interquartile range (IQR), 12-35] days versus 20 [IQR, 12-35] days; P = .119) and in-hospital mortality (10.9% [n = 76/698] vs 12.4% [n = 24/193]; P = .547) were comparable in the 2 groups. Long-term survival was significantly better in the DLRTx group (P < .001, log-rank test). In the propensity score-weighted multivariable model, the DLRTx group had 28% lower risk of mortality at any point during follow-up compared to the SLRTx group (hazard ratio, 0.72; 95% confidence interval, 0.57-0.91; P = .006). CONCLUSIONS: The less invasiveness of single-lung transplantation in the retransplantation setting has minimal short-term benefit and is associated with significantly worse long-term survival. Double-lung retransplantation should remain the standard for lung retransplantation after initial double-lung transplantation.
引用
- Yin V, Rodman JCS, Atay SM, et al. Outcomes of single-lung retransplantation after double-lung transplantation. J Thorac Cardiovasc Surg. 2024. PMID: 39357566. doi:10.1016/j.jtcvs.2024.09.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。